Christopher E. Duymich
Impact in
-
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Genomics and Chromatin Dynamics
- Chromatin Remodeling and Cancer
Papers in
-
- Ferroptosis and cancer prognosis 1
- Prostate Cancer Diagnosis and Treatment 1
-
- Epigenetics and DNA Methylation 5
- Cancer-related gene regulation 2
- Renal and related cancers 1
- RNA modifications and cancer 1
- Co-authors
- Gangning Liang (7 shared papers)Peter Anthony Jones (6 shared papers)Jessica Charlet (3 shared papers)Xiaojing Yang (1 shared paper)Daniel J. Weisenberger (3 shared papers)Kamilla Mundbjerg (2 shared papers)Karina Dalsgaard Sørensen (2 shared papers)Hongtao Li (1 shared paper)
- Journals
- Nature Communications (1 paper)The Journal of Urology (1 paper)Cancer Research (1 paper)Cancer Letters (1 paper)Molecular Cell (1 paper)
- Partner nations
- United StatesDenmarkSouth Korea
In The Last Decade
Christopher E. Duymich
7 papers receiving 385 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 60
- Molecular Biology 297
- Reproductive Medicine 17
- Pathology and Forensic Medicine 30
- Pulmonary and Respiratory Medicine 46
Countries citing papers authored by Christopher E. Duymich
This map shows the geographic impact of Christopher E. Duymich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Duymich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Duymich more than expected).
Fields of papers citing papers by Christopher E. Duymich
This network shows the impact of papers produced by Christopher E. Duymich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Duymich. The network helps show where Christopher E. Duymich may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher E. Duymich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 111 | |
| 2 | 2016 | 97 | |
| 3 | 2016 | 58 | |
| 4 | 2017 | 50 | |
| 5 | 2017 | 43 | |
| 6 | 2016 | 29 | |
| 7 | 2017 | 2 |
About Christopher E. Duymich
Christopher E. Duymich is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Reproductive Medicine, Pathology and Forensic Medicine and Surgery, having authored 7 papers that have together received 390 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (2 papers), Cancer Mechanisms and Therapy (1 paper), Ferroptosis and cancer prognosis (1 paper), Renal and related cancers (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Prostate Cancer Diagnosis and Treatment (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (60 citations), Molecular Biology (297 citations), Reproductive Medicine (17 citations), Pathology and Forensic Medicine (30 citations) and Pulmonary and Respiratory Medicine (46 citations). Christopher E. Duymich has collaborated with scholars based in United States, Denmark and South Korea. Frequent co-authors include Gangning Liang, Peter Anthony Jones, Jessica Charlet, Xiaojing Yang, Daniel J. Weisenberger, Kamilla Mundbjerg, Karina Dalsgaard Sørensen, Hongtao Li, Fides D. Lay and Ranjani Lakshminarasimhan. Their work appears in journals such as Nature Communications, The Journal of Urology, Cancer Research, Cancer Letters and Molecular Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.